Literature DB >> 13900478

Actinonin: an antibiotic substance produced by an actinomycete.

J J GORDON, B K KELLY, G A MILLER.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/chemistry

Mesh：

Substances：

Year:  1962        PMID： 13900478     DOI： 10.1038/195701b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  23 in total

1.  High-throughput identification of inhibitors of human mitochondrial peptide deformylase.

Authors:  Christophe Antczak; David Shum; Sindy Escobar; Bhramdeo Bassit; Earl Kim; Venkatraman E Seshan; Nian Wu; Guangli Yang; Ouathek Ouerfelli; Yue-Ming Li; David A Scheinberg; Hakim Djaballah
Journal:  J Biomol Screen       Date:  2007-04-13

2.  Killing of macrophages by anthrax lethal toxin: involvement of the N-end rule pathway.

Authors:  Katherine E Wickliffe; Stephen H Leppla; Mahtab Moayeri
Journal:  Cell Microbiol       Date:  2008-02-05       Impact factor: 3.715

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

4.  Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.

Authors:  Thomas R Fritsche; Helio S Sader; Roy Cleeland; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.

Authors:  Xuchun Che; Jinwei Hu; Lijuan Wang; Zhifeng Zhu; Qiong Xu; Junqiang Lv; Zheng Fu; Yajun Sun; Jia Sun; Gang Lin; Rong Lu; Zhi Yao
Journal:  Mol Cell Biochem       Date:  2011-05-21       Impact factor: 3.396

6.  Peptide deformylase inhibitors as potent antimycobacterial agents.

Authors:  Jeanette W P Teo; Pamela Thayalan; David Beer; Amelia S L Yap; Mahesh Nanjundappa; Xinyi Ngew; Jeyaraj Duraiswamy; Sarah Liung; Veronique Dartois; Mark Schreiber; Samiul Hasan; Michael Cynamon; Neil S Ryder; Xia Yang; Beat Weidmann; Kathryn Bracken; Thomas Dick; Kakoli Mukherjee
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

7.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.

Authors:  Huamei Fu; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.

Authors:  Corinne J Hackbarth; Dawn Z Chen; Jason G Lewis; Kirk Clark; James B Mangold; Jeffrey A Cramer; Peter S Margolis; Wen Wang; Jim Koehn; Charlotte Wu; S Lopez; George Withers; Helen Gu; Elina Dunn; R Kulathila; Shi-Hao Pan; Wilma L Porter; Jeff Jacobs; Joaquim Trias; Dinesh V Patel; Beat Weidmann; Richard J White; Zhengyu Yuan
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Staphylococcus aureus formyl-methionyl transferase mutants demonstrate reduced virulence factor production and pathogenicity.

Authors:  Thomas Lewandowski; Jianzhong Huang; Frank Fan; Shannon Rogers; Daniel Gentry; Reannon Holland; Peter Demarsh; Kelly Aubart; Magdalena Zalacain
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.